Events
TLC599 showed locally sustained release profile up to 120 days, dose proportionality, minimal systemic exposure and potential for repeat dosing
A year ago, GENFIT gathered an international coalition to support The NASH Education Program and launch the 1st successful edition of International NASH Day
Heidelberg Pharma AG announced that they will present their proprietary technology for Antibody Targeted Amanitin Conjugates as potential therapeutic modality for cancer therapy at two upcoming scientific conferences.
Sugar.IQ Insights Viewed as Helpful and Enable Users to Avoid Diabetes-Related Events up to Four Hours in Advance
Approximately 9,000 employees participate in volunteer activities to update schools and community centers all over the world benefitting more than 70,000 students and 50,000 community members
Nationally Recognized Non-Profit Hosts Ribbon Cutting Ceremony to Celebrate 75 New Frederick County Jobs
With the treatment center at the Paracelsus Clinic in Zwickau another geographically important location will soon offer NanoTherm therapy for brain tumor patients
CYROLITE® acrylic-based polymers have been a proven material in medical technology for over 40 years.
Polyphor AG presented yesterday new data from pulmonary delivery of its lead antibacterial candidate of the novel Outer Membrane Protein Targeting Antibiotic class, murepavadin, at the 42nd European Cystic Fibrosis Conference in Liverpool, United Kingdom.
ArcheMedX is pleased to announce the launch of Ready, a new digital platform to reduce the risks and costs associated with under-performing clinical trials, at this year’s Drug Information Association Global Annual Meeting from June 23-27 in San Diego, CA.
PRESS RELEASES